Home > Insider Trading > Filing (0001477449-25-000082)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	Services-Offices & Clinics Of Doctors Of Medicine (8011)	043705970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2036989	Kelly Bliss	C/O Teladoc Health, Inc., 155 E 44Th St, Floor 17 New York NY 10017	President, U.s. Group Health	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-05-30	1,189	$0.00	46,573	No	4	M	Direct
Common Stock	Acquisiton	2025-05-30	3,488	$0.00	50,061	No	4	M	Direct
Common Stock	Acquisiton	2025-05-30	4,858	$0.00	54,919	No	4	M	Direct
Common Stock	Disposition	2025-06-02	4,653	$6.86	50,266	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Disposition	2025-05-30	1,189	$0.00	1,189	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-05-30	3,488	$0.00	3,488	$0.00
Common Stock	Restricted Stock Units	Disposition	2025-05-30	4,858	$0.00	4,858	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,564	No	4	M	Direct
10,464	No	4	M	Direct
34,009	No	4	M	Direct

Footnotes

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.